UPDATE : Friday, August 14, 2020
상단여백
Pharmacists demand audit over Gliatilin’s insurance benefit by Song Soo-youn 2019-08-27 16:01
HLB to test rivoceranib+Lonsurf in colon cancer by Jeong Sae-im 2019-08-27 15:39
Pharmaceutical sector’s job growth twice of all industries’ average by Jeong Sae-im 2019-08-26 11:39
Invossa still effective despite mislabeling, maker claims by Lee Han-soo 2019-08-23 20:16
Vivozon finishes P3 trial for nonnarcotic analgesics by Lee Han-soo 2019-08-23 16:03
라인
HLB wins FDA nod for P2 trial on rivoceranib in adenoid cystic carcinoma by Jeong Sae-im 2019-08-23 15:02
Ministry OKs P1 trial into Haim Bio’s metabolism anticancer drug by Lee Han-soo 2019-08-23 13:53
'Peptron's Parkinson's disease treatment blocks levodopa side effects' by Lee Han-soo 2019-08-22 17:53
‘Drug firm’s pick of doctor to attend conference overseas illegal’ by Kim Yun-mi 2019-08-22 15:45
SK Biopharmaceutical’s sleepiness drug initially aimed to treat depression by Lee Hye-seon 2019-08-22 15:37
라인
Tego Science’s diabetic foot ulcer treatment gets insurance benefit by Lee Han-soo 2019-08-22 15:34
Australia OKs Daewoong's P1 trial for idiopathic pulmonary fibrosis treatment by Lee Han-soo 2019-08-22 14:36
K-Hospital Fair 2019 opens 3-day show in Seoul by Lee Han-soo 2019-08-21 23:36
Chong Kun Dang invests ₩5 billion in Biorchestra by Lee Han-soo 2019-08-21 16:42
‘GSK’s hair loss treatment Avodart works well for Koreans’ by Lee Han-soo 2019-08-20 17:46
라인
JW’s European partner launches 3rd-gen parenteral nutrition solution in EU by Lee Han-soo 2019-08-20 17:46
Genexine, Toolgen merger deal falls through by Lee Han-soo 2019-08-20 11:21
Combo drugs: latest trend in local pharmaceuticals by Lee Hye-seon 2019-08-19 16:02
Boryung to sell antihypertensive drugs in Mexico by Lee Han-soo 2019-08-19 14:31
Rivalry among PARP inhibitors intense in ovarian cancer treatment by Kim Yun-mi 2019-08-19 14:00
여백
여백
여백
Back to Top